申请人:Danvy Denis
公开号:US20050027013A1
公开(公告)日:2005-02-03
The invention relates to compounds which constitute a class of medicaments which have an anti-inflammatory activity and which act by inhibiting leukotriene A
4
(LTA
4
), and enzyme which is responsible for the biosynthesis of leukotriene LTB
4
, a major proinflammatory mediator. The invention also relates to therapeutic anti-inflammatory, applications of these compounds as well as for methods of preparing these compounds.
本发明涉及一类化合物,它们是一类具有抗炎活性并通过抑制白三烯A4(LTA4)而发挥作用的药物,该酶负责白三烯LTB4的生物合成,是一种主要的促炎介质。本发明还涉及这些化合物的治疗抗炎应用,以及制备这些化合物的方法。